Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1953 1
1954 1
1956 1
1957 2
1958 2
1959 1
1961 7
1962 6
1963 5
1964 6
1965 4
1966 7
1967 6
1968 6
1969 11
1970 8
1971 9
1972 19
1973 8
1974 9
1975 18
1976 13
1977 17
1978 16
1979 18
1980 17
1981 15
1982 16
1983 22
1984 17
1985 20
1986 19
1987 17
1988 19
1989 20
1990 23
1991 16
1992 22
1993 23
1994 32
1995 45
1996 42
1997 67
1998 52
1999 72
2000 73
2001 66
2002 63
2003 70
2004 84
2005 74
2006 76
2007 88
2008 91
2009 84
2010 78
2011 93
2012 114
2013 90
2014 101
2015 90
2016 113
2017 83
2018 112
2019 112
2020 107
2021 122
2022 110
2023 111
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

2,780 results

Results by year

Filters applied: . Clear all
Page 1
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H, Hirano Y, Koike S, Sasabayashi D, Katayama H, Plitman E, Ohi K, Ueno F, Caravaggio F, Koizumi T, Gerretsen P, Suzuki T, Uchida H, Müller DJ, Mimura M, Remington G, Grace AA, Graff-Guerrero A, Nakajima S. Wada M, et al. Mol Psychiatry. 2022 Jul;27(7):2950-2967. doi: 10.1038/s41380-022-01572-0. Epub 2022 Apr 20. Mol Psychiatry. 2022. PMID: 35444257 Review.
Foreword.
Wada M. Wada M. Chem Pharm Bull (Tokyo). 2023;71(1):9. doi: 10.1248/cpb.c23-ctf7101. Chem Pharm Bull (Tokyo). 2023. PMID: 36596516 Free article. No abstract available.
Pediatric intestinal rehabilitation.
Kudo H, Wada M. Kudo H, et al. Among authors: wada m. Curr Opin Organ Transplant. 2023 Jun 1;28(3):237-241. doi: 10.1097/MOT.0000000000001062. Epub 2023 Apr 12. Curr Opin Organ Transplant. 2023. PMID: 37053076 Review.
Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
Chiba M, Masumoto K, Kaji T, Matsuura T, Morii M, Fagbemi A, Hill S, Pakarinen MP, Protheroe S, Urs A, Chen ST, Sakui S, Udagawa E, Wada M. Chiba M, et al. Among authors: wada m. J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):339-346. doi: 10.1097/MPG.0000000000003867. Epub 2023 Jun 26. J Pediatr Gastroenterol Nutr. 2023. PMID: 37364133 Free PMC article. Clinical Trial.
The Authors' Reply.
Mori D, Kobayashi M, Wada M, Tokuchi M, Misegawa S, Saito R, Nomi H, Haga R, Nagatoya K, Yamauchi A. Mori D, et al. Among authors: wada m. Intern Med. 2024 Jan 2. doi: 10.2169/internalmedicine.3074-23. Online ahead of print. Intern Med. 2024. PMID: 38171866 Free article. No abstract available.
Authors' reply.
Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, Nakamura K, Onodera O, Narita I. Wakasugi M, et al. Among authors: wada m. J Bone Miner Metab. 2022 May;40(3):537-538. doi: 10.1007/s00774-022-01315-9. Epub 2022 Feb 20. J Bone Miner Metab. 2022. PMID: 35184207 No abstract available.
Severe Psychosis Associated With Lorlatinib.
Kunimasa K, Wada M, Nishino K. Kunimasa K, et al. Among authors: wada m. J Thorac Oncol. 2023 Jul;18(7):e71-e72. doi: 10.1016/j.jtho.2023.03.025. J Thorac Oncol. 2023. PMID: 37348995 No abstract available.
Untangling the threads of cellulose mercerization.
Sawada D, Nishiyama Y, Shah R, Forsyth VT, Mossou E, O'Neill HM, Wada M, Langan P. Sawada D, et al. Among authors: wada m. Nat Commun. 2022 Oct 19;13(1):6189. doi: 10.1038/s41467-022-33812-w. Nat Commun. 2022. PMID: 36261428 Free PMC article.
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.
Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, Segawa H, Hondo N, Mori Y, Watanabe H, Nakahara K, Yoshida K, Wada M, Tarumi R, Iwata Y, Plitman E, Moriguchi S, de la Fuente-Sandoval C, Uchida H, Mimura M, Graff-Guerrero A, Nakajima S. Nakahara T, et al. Among authors: wada m. Mol Psychiatry. 2022 Jan;27(1):744-757. doi: 10.1038/s41380-021-01297-6. Epub 2021 Sep 28. Mol Psychiatry. 2022. PMID: 34584230 Review.
2,780 results